FINALS

Subdecks (1)

Cards (890)

  • Asilo, Carles, Dela Cruz, Valencia are students in Clinical Pharmacy.
  • Brands are usually expensive for their advertisements.
  • Brands are usually copied.
  • Clinical Pharmacy is 150 (IPPE in Philippine Health Care System).
  • What we can do to secure and ensure the safety of health products used by the general public is a matter of public concern.
  • Updates and established health products are done every Tuesday.
  • Sending a report at info@gov.ph is one way to provide feedback on health product safety.
  • Generic drugs with the name and photo of the product, the place where it was bought, and other necessary details can be found in the Generic Drugs 101 and Overview of Public Act No. 6675.
  • Págayuna Legal Services Support Center is headed by Atty. Emilio L. Polig, Jr.
  • The Common Services Laboratory is headed by Dr. Jocelyn E. Baderrama.
  • The Policy and Planning Service is headed by Irene Florentino-Fariñas and provides assistance in drafting of policies and plans.
  • The Information, Communication, and Technology Management Division is headed by Mr. Kenneth I. Dacallos.
  • The Food and Drug Action Center is headed by Estrellita B. Pastorero.
  • Branded drugs are more expensive, have a slightly different taste, and are available in a variety of dosages.
  • Generic drugs add food preservatives and flavorings to mask the bitter taste of medicines.
  • Generic manufacturers do not advertise the drug to the public.
  • Comparison: Generic drugs and branded drugs have the same safety, efficacy, active ingredients, good quality, correct dosage, and FDA approval.
  • Branded drugs are believed by many to be more effective than generic drugs.
  • Generic drugs are cheaper, have a slightly different taste, and are available in a variety of dosages.
  • The Center for Cosmetics and Household/Urban Hard Substances Regulation (CHUHSR) regulates cosmetics, household/urban hard substances, toys, and children's articles (under 14 years old).
  • The Center for Drug Evaluation and Research (CDER) licenses and regulates drugs, biologics, and medical devices.
  • Health products covered include means of food, drugs, cosmetics, devices, biologicals, vaccines, in-vitro diagnostic regents, and household/urban hard sustenances.
  • The second conviction is a penalty of fine (2,000 - 5,000).
  • Suspension of license to practice for 3 days is a possible outcome of the fourth conviction.
  • The first conviction is a penalty of reprimand, recorded in the appropriate books of the PRC.
  • The third conviction is a penalty of fine (5,000 - 10,000).
  • The fifth conviction results in the suspension or revocation of license to practice for one year or longer.
  • Implementing guidelines for the exclusive use of generic names or generic terminology in all prescriptions and orders in all Doha facilities provides guidelines in the mandatory use of generic names in all Doha facilities and without the corresponding brand names.
  • The use of generic names in all Doha facilities provides a system of monitoring compliance to generic prescriptions.
  • The use of generic names in all Doha facilities contributes to the institutionalization of promoting generic names and drugs by identifying the key person in the Doha and their corresponding roles and responsibilities.
  • A system of monitoring compliance to generic prescriptions is established in Doha facilities.
  • Former President Corazon Cojuangco Aquino amended RA 3720, which was the Food, Drugs and Devices, and Cosmetics Act.
  • Former President Benigno Aquino III signed RA 10643, which renamed the Bureau of Food and Drugs to the Food and Drug Administration.
  • Former President Ferdinand Marcos Sr. signed BFAD as its first ever Bureau of Food and Drug.
  • Former President Gloria Macapagal-Arroyo signed FDA Administrative Act of 2009.
  • The guiding principle of the current structure and processes of FDA is the establishment of adequate laboratories and regional offices.
  • The vision of the FDA is to be an internationally recognized center of excellence in health product regulation by 2026.
  • Directly reports to the secretary of health (Theodore "Ted" J Herbos).
  • Regulates a vast array of products and medicines that touch every aspect of our lives, from the foods we consume to the medicines we rely on.
  • Functions as a regulatory body to get together with the Health Facilities and Services Regulatory Bureau (HFSRB), Bureau of Quarantine (BOQ), Health Technology Assessment Division (HTAD), Malasakit Program Office (MPO), and Philippine Institute of Traditional and Alternative Health Care (PITAHC).